ARCHIVES

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Breast Cancer Task Force Suggests 12 New Projects For RFPs, Hears Report On Hormones

January 16, 1976

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014

NCI Community Cancer Centers RFP Issued; Advisors Criticize Project Structure.

November 10, 2006

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011